According to the report the global acute kidney injury treatment market reached a value of USD 41.65 billion in 2022. Aided by the increasing incidence of acute kidney injuries worldwide and the advancement in therapeutic approaches, the market is projected to further grow at a CAGR of 6.20% between 2023 and 2028 to reach a value of USD 59.78 billion by 2028.
Acute Kidney Injury (AKI) is a sudden episode of kidney failure or damage that happens within a few hours or days. It results in an accumulation of waste products in the blood that can be fatal. The primary treatments for AKI revolve around addressing the causative factors, which could range from severe infections, certain medications, or a direct blow to the kidneys. Over the years, the methods to diagnose and treat AKI have seen significant advancements, with a focus on early diagnosis and prompt intervention, thereby ensuring better patient outcomes.
The escalating prevalence of conditions like sepsis, heart diseases, and certain kidney diseases that predispose individuals to AKI is fuelling the acute kidney injury treatment market growth. The modern sedentary lifestyle, marked by poor dietary habits and minimal physical activity, has seen a spike in conditions like diabetes and hypertension, which indirectly increase the risk of AKI.
Moreover, the global ageing population is another critical factor underpinning the market expansion. Elderly individuals are more susceptible to AKI due to reduced kidney function with age and the presence of other chronic ailments. Their treatment often necessitates specialised therapeutic modalities, thus driving the acute kidney injury treatment market demand.
Technological advancements in medical science have paved the way for innovative therapeutic approaches. The emergence of novel drugs, refined dialysis techniques, and state-of-the-art equipment for monitoring kidney functions have revolutionised AKI treatment. These advancements not only ensure prompt and effective treatment but also reduce the duration of hospital stays and associated costs.
Furthermore, the pharmaceutical sector's tireless endeavours in research and development are continuously broadening the treatment horizons for AKI. There are several drugs in the pipeline, awaiting approval, which promise better efficacy and fewer side effects. These potential market entries, coupled with the existing treatment modalities, are poised to impact the acute kidney injury treatment market outlook.
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
These high-quality, data-driven analysis provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organisation's future success by acquiring one of our these reports today.
*The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.
Acute Kidney Injury (AKI) is a sudden episode of kidney failure or damage that happens within a few hours or days. It results in an accumulation of waste products in the blood that can be fatal. The primary treatments for AKI revolve around addressing the causative factors, which could range from severe infections, certain medications, or a direct blow to the kidneys. Over the years, the methods to diagnose and treat AKI have seen significant advancements, with a focus on early diagnosis and prompt intervention, thereby ensuring better patient outcomes.
The escalating prevalence of conditions like sepsis, heart diseases, and certain kidney diseases that predispose individuals to AKI is fuelling the acute kidney injury treatment market growth. The modern sedentary lifestyle, marked by poor dietary habits and minimal physical activity, has seen a spike in conditions like diabetes and hypertension, which indirectly increase the risk of AKI.
Moreover, the global ageing population is another critical factor underpinning the market expansion. Elderly individuals are more susceptible to AKI due to reduced kidney function with age and the presence of other chronic ailments. Their treatment often necessitates specialised therapeutic modalities, thus driving the acute kidney injury treatment market demand.
Technological advancements in medical science have paved the way for innovative therapeutic approaches. The emergence of novel drugs, refined dialysis techniques, and state-of-the-art equipment for monitoring kidney functions have revolutionised AKI treatment. These advancements not only ensure prompt and effective treatment but also reduce the duration of hospital stays and associated costs.
Furthermore, the pharmaceutical sector's tireless endeavours in research and development are continuously broadening the treatment horizons for AKI. There are several drugs in the pipeline, awaiting approval, which promise better efficacy and fewer side effects. These potential market entries, coupled with the existing treatment modalities, are poised to impact the acute kidney injury treatment market outlook.
Market Segmentation
The market can be divided based on type, treatment, end user, and region.Market Breakup by Type
- Prerenal Acute Kidney Injury
- Intrinsic Renal Acute Kidney Injury
- Postrenal Acute Kidney Injury
- Others
Market Breakup by Treatment
- Dialysis
- Supportive Care
Market Breakup by End User
- Hospitals
- Ambulatory Surgical Centres
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Competitive Landscape
The report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the leading companies operating in the global acute kidney injury treatment market. Some of the major players explored in the report are as follows:- Angion
- AM-Pharma B.V.
- Baxter International, Inc.
- Fresenius Medical Care Holdings, Inc.
- Asahi Kasei Medical Co., Ltd.
- B. Braun Melsungen AG
- Others
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
These high-quality, data-driven analysis provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organisation's future success by acquiring one of our these reports today.
*The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.
Table of Contents
1 Preface2 Report Coverage - Key Segmentation and Scope4 Key Assumptions7 Opportunities and Challenges in the Market16 Key Trends and Developments in the Market
3 Report Description
5 Executive Summary
6 Snapshot
8 Global Acute Kidney Injury Treatment Market Analysis
9 North America Acute Kidney Injury Treatment Market Analysis
10 Europe Acute Kidney Injury Treatment Market Analysis
11 Asia Pacific Acute Kidney Injury Treatment Market Analysis
12 Latin America Acute Kidney Injury Treatment Market Analysis
13 Middle East and Africa Acute Kidney Injury Treatment Market Analysis
14 Market Dynamics
15 Competitive Landscape
List of Key Figures and Tables
Companies Mentioned
- Angion
- AM-Pharma B.V.
- Baxter International Inc.
- Fresenius Medical Care Holdings Inc.
- Asahi Kasei Medical Co. Ltd.
- B. Braun Melsungen AG
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 143 |
| Published | September 2023 |
| Forecast Period | 2023 - 2028 |
| Estimated Market Value ( USD | $ 44.25 Billion |
| Forecasted Market Value ( USD | $ 59.78 Billion |
| Compound Annual Growth Rate | 6.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 6 |
